Covington & Burling litigators scored a major win for Eli Lilly & Co. last week when a panel of arbitrators rejected trade secret misappropriation claims by French biotech company Adocia S.A.

Adocia, which was represented by Jones Day, sought at least $1.39 billion in damages. The two companies in 2014 teamed up to develop a rapid-acting insulin.  But the collaboration didn’t last, and Adocia went on to claim Lilly misappropriated and misused its confidential information and discoveries.